Health CanadaType I
TEVA-Betahistine Tablets: Affected lots exceed or may exceed the interim accepta...
Published: December 4, 2024Recall ID: 76642Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.
Affected Products
TEVA-Betahistine Tablets
Additional Source Details
| Field | Value |
|---|---|
| N I D | 76642 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/teva-betahistine-tablets-affected-lots-exceed-or-may-exceed-interim-acceptable-intake |
| Issue | Product safety |
| Title | TEVA-Betahistine Tablets: Affected lots exceed or may exceed the interim acceptable intake limit for N-nitroso-betahistine. |
| Product | TEVA-Betahistine Tablets |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2024-12-04 |
| Organization | Drugs and health products |
| Recall class | Type I |
| What you should do | Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada. |